FIGS
FIGS, Inc.
FIGS has the edge over LCID overall, supported by stronger valuation and stronger fundamentals.
LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
FIGS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
FIGS's revenue, profitability, cash flow and balance sheet are all currently healthy.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
FIGS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 48x | $18.14 | -20% |
| Forward | 57x | $22.68 | — |
| Current | 60x | $22.68 | — |
| Fair | 86x | $32.55 | +43% |
| Expensive | 177x | $67.36 | +197% |
Historical ranges are pointers, not guarantees.
FIGS's PE is in its cheap range at 60x. If earnings grow as analysts expect, today's price would be 57x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
FIGS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for FIGS, with profitability improving. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
FIGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.40 | +5.3% |
| Q3 2026 | $0.38 | +280% |
| Q2 2026 | $0.33 | +725% |
| Q1 2026 | $0.22 | +2100% |
| Q4 2025 | $0.19 | +850% |
| Q3 2025 | $0.10 | +43% |
| Q2 2025 | $0.04 | -64% |
| Q1 2025 | $0.01 | -92% |
| Q4 2024 | $0.02 | -83% |
FIGS has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
FIGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $190.7M | +26% |
| Q2 2026 | $196.6M | +29% |
| Q1 2026 | $159.9M | +28% |
| Q4 2025 | $201.9M | +33% |
| Q3 2025 | $151.7M | +8.2% |
| Q2 2025 | $152.6M | +5.8% |
| Q1 2025 | $124.9M | +4.7% |
| Q4 2024 | $151.8M | +4.8% |
FIGS's revenue has grown year over year for eight quarters in a row: $191M last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +5.3 points |
| Q2 2026 | 18% | +11 points |
| Q1 2026 | 2.8% | +3 points |
| Q4 2025 | 9.3% | +3.5 points |
| Q3 2025 | 6.3% | +13 points |
| Q2 2025 | 6.5% | +5.4 points |
| Q1 2025 | -0.2% | -0.5 points |
| Q4 2024 | 5.9% | -4 points |
FIGS has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over FIGS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
FIGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $51.2M | +9538% |
| Q2 2026 | $44.3M | +$57.8M |
| Q1 2026 | -$5.6M | -171% |
| Q4 2025 | $58.1M | +115% |
| Q3 2025 | $531K | -97% |
| Q2 2025 | -$13.5M | -279% |
| Q1 2025 | $7.9M | -29% |
| Q4 2024 | $27.1M | +98% |
FIGS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
FIGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -1.9M shares |
| 1 year | +6.9% | +12.4M shares |
| 3 years | +6.5% | +11.8M shares |
| 5 years | +23% | +36.4M shares |
| Available history | +21% | +33.1M shares |
FIGS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $13.8M |
| Q2 2026 | $24M |
| Q1 2026 | $8.8M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $2.7M |
| Q4 2024 | $38.2M |
FIGS spent $47M buying back its own shares over the past year, up 14% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
FIGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -2.7x | Net Cash |
| Q1 2025 | -9.5x | Net Cash |
| Q4 2024 | -9.6x | Net Cash |
FIGS has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
FIGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.3 | Overbought |
| Stochastic | 87.1 | Overbought |
FIGS's weekly RSI is 73 (overbought) and its Stochastic is 87 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
FIGS PE vs Consumer Cyclical Sector
| Metric | FIGS | Sector median | Relative |
|---|---|---|---|
| PE | 60x | 18x | 231% above |
| PE % | 32 | 54 | 22 pts below |
FIGS is trading at 60x earnings, a 231% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
FIGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.2 | 24% above |
| 20 week MA | $14.8 | 53% above |
| 50 week MA | $13.6 | 67% above |
| 100 week MA | $9.82 | 131% above |
| 200 week MA | $8.09 | 180% above |
FIGS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
FIGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $34.2 | $26.4 | -23% |
| 2022 | $26.4 | $6.72 | -75% |
| 2023 | $6.72 | $6.95 | +3.4% |
| 2024 | $6.95 | $6.01 | -14% |
| 2025 | $6.01 | $11.8 | +97% |
| 2026 YTD | $11.8 | $22.7 | +92% |
FIGS has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.